Takeshita A, Mark A L, Eckberg D L, Abboud F M
Am J Physiol. 1979 Jan;236(1):H42-7. doi: 10.1152/ajpheart.1979.236.1.H42.
There is considerable evidence that the level of afferent cardiopulmonary receptor activity modulates sinus node responses to arterial baroreflex stimulation in experimental animals. We tested the hypothesis that this reflex interaction occurs also in man by measuring sinus node responses to arterial baroreceptor stimulation with phenylephrine injection or neck suction, before and during changes of central venous pressure provoked by lower body negative pressure or leg and lower trunk elevation. Variations of central venous pressure between 1.1 and 9.0 mmHg did not influence arterial baroreflex mediated bradycardia. Baroreflex sinus node responses were augmented by intravenous propranolol, but the level of responses after propranolol was comparable during the control state, lower body negative pressure, and leg and trunk elevation. Sinus node responses to very brief baroreceptor stimuli applied during the transitions of central venous pressure also were comparable in the three states. We conclude that physiological variations of central venous pressure do not influence sinus node responses to arterial baroreceptor stimulation in man.
有大量证据表明,在实验动物中,传入性心肺感受器活动水平可调节窦房结对动脉压力反射刺激的反应。我们通过在下肢负压或腿部及下躯干抬高引起中心静脉压变化之前和期间,测量用去氧肾上腺素注射或颈部吸引刺激动脉压力感受器时窦房结的反应,来检验这一反射相互作用在人类中也存在的假设。中心静脉压在1.1至9.0 mmHg之间的变化并未影响动脉压力反射介导的心动过缓。静脉注射普萘洛尔可增强压力反射性窦房结反应,但在对照状态、下肢负压以及腿部和躯干抬高期间,普萘洛尔后的反应水平相当。在中心静脉压转变期间施加的非常短暂的压力感受器刺激所引起的窦房结反应在这三种状态下也相当。我们得出结论,中心静脉压的生理变化不会影响人类窦房结对动脉压力感受器刺激的反应。